Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Oct 20 2024
Business
Oct 20 2024
4 min read

Press Release Oct 20 2024

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 20, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, and 240 mg".

View Attachment